Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	ABCA2 ABCA3 ABCF1 KIF27 MYO6 CHD9 MYO1B ZNFX1 DNAH1 ACSL4 DDX50 SHOC1 MYH15 DNAH9 TOP2B AQR HSP90AB1	4.19e-06	614	151	17	GO:0140657
GeneOntologyMolecularFunction	transferrin receptor activity	TFR2 TFRC	5.68e-05	2	151	2	GO:0004998
GeneOntologyMolecularFunction	cytoskeletal motor activity	KIF27 MYO6 MYO1B DNAH1 MYH15 DNAH9	2.78e-04	118	151	6	GO:0003774
GeneOntologyMolecularFunction	actin filament binding	MYO6 SYNE1 SPTAN1 CAMSAP3 MYO1B TWF2 LCP1 MYH15	3.40e-04	227	151	8	GO:0051015
GeneOntologyCellularComponent	HFE-transferrin receptor complex	TF TFR2 TFRC	2.01e-05	8	151	3	GO:1990712
GeneOntologyCellularComponent	glutamatergic synapse	CACNB4 MYO6 FZD3 SPTAN1 SH3GL3 CNTNAP1 PSD3 SH3GLB2 CSMD2 ADAM22 CDKL5 PPP3CA AKAP9 FLRT2 FYN PCDH10 RAB4A AP3D1	2.59e-05	817	151	18	GO:0098978
GeneOntologyCellularComponent	postsynapse	MYO6 USP9X SYNE1 SPTAN1 SH3GL3 PSD3 SH3GLB2 CSMD2 ZZEF1 ADAM22 TFR2 TFRC CDKL5 PPP3CA AKAP9 FLRT2 FYN PCDH10 RAB4A AP3D1	4.57e-05	1018	151	20	GO:0098794
GeneOntologyCellularComponent	actin-based cell projection	MYO6 FZD3 SLC34A2 MYO1B TWF2 ADGRV1 LCP1 RUFY3 LOXHD1	1.95e-04	278	151	9	GO:0098858
GeneOntologyCellularComponent	filopodium	MYO6 FZD3 MYO1B TWF2 LCP1 RUFY3	2.73e-04	123	151	6	GO:0030175
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	CUL1 NUP50 ABCF1 USP9X ERO1A SPTAN1 BAG2 TBC1D2 NUCB2 SH3GLB2 CC2D1B NCBP1 TWF2 ZZEF1 FANCD2 CSDE1 CSE1L PPP3CA SEC24C MAGED2 P4HB DNAAF10 RABGEF1 NUDCD1 AP3D1 HSP90AB1	9.95e-10	1455	152	26	22863883
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	CACNB4 ABCF1 MYO6 USP9X SYNE1 SPTAN1 CNTNAP1 CAMSAP3 PSD3 TWF2 ZNFX1 TF ADAM22 ALG2 RUFY3 CSDE1 CDKL5 CSE1L PPP3CA SEC24C SUGP2 P4HB AP3D1 PCM1 HSP90AB1	3.43e-09	1431	152	25	37142655
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RAPGEF5 SYNE1 PSD3 ADCY2 CSDE1 AKAP9 SEC24C SUGP2 ZNF644 MCM3AP ANKRD12 SPEN PCDH10 AQR	3.64e-09	407	152	14	12693553
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	CUL1 USP9X SH3GLB2 MYO1B TWF2 RUFY3 TDRD3 PPP3CA ZNF644 MCM3AP MED25 PATJ SPEN LRIF1 PCM1 KNL1	7.50e-09	588	152	16	38580884
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	NPC1 NUP50 ERO1A SPTAN1 CNTNAP1 NUCB2 GATM MYO1B UFL1 IKBIP TFRC CSDE1 TDRD3 PPP3CA SEC24C DDX50 P4HB UGGT2 FYN AP3D1 PCM1 AQR HSP90AB1	1.19e-08	1297	152	23	33545068
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	HAUS6 MYO6 RPAP3 USP9X BAG2 PSD3 CC2D1B MYO1B TFRC CSDE1 CSE1L SEC24C MAGED2 ARHGAP29 PATJ AP3D1 HSP90AB1	1.56e-08	708	152	17	39231216
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	CUL1 USP9X SPTAN1 BAG2 NCBP1 UFL1 TFRC CSDE1 CSE1L SEC24C SUGP2 MAGED2 P4HB AP3D1 TOP2B HSP90AB1	2.34e-08	638	152	16	33239621
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	PDE3B ABCF1 MYO6 RPAP3 ERO1A SYNE1 SPTAN1 BAG2 NUCB2 APAF1 PSD3 UFL1 IKBIP TFRC AKAP9 SEC24C P4HB ZNF644 UGGT2 PPIE AP3D1 TOP2B PCM1 AQR	3.31e-08	1487	152	24	33957083
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	NUP50 RPAP3 USP9X SPTAN1 BAG2 CAMSAP3 PSD3 NCBP1 MYO1B FANCD2 ACSL4 TDRD3 CSE1L PPP3CA AKAP9 DDX50 P4HB DNAAF10 KNL1 HSP90AB1	3.64e-08	1049	152	20	27880917
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	NPC1 SEMA4D ABCA2 ABCF1 MYO6 USP9X SYNE1 SPTAN1 CNTNAP1 GATM SH3GLB2 CHD9 NCBP1 ZNFX1 TF ADAM22 RUFY3 CSDE1 FRY PPP3CA PCM1 HSP90AB1	4.75e-08	1285	152	22	35914814
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	CUL1 NUP50 ABCF1 KIF27 MYO6 USP9X ERO1A SYNE1 SPTAN1 NCBP1 MYO1B UFL1 TFRC FANCD2 CSE1L DDX50 MAGED2 P4HB SGO2 SPEN TOP2B AQR HSP90AB1	6.61e-08	1425	152	23	30948266
Pubmed	The role of transferrin receptor 1 and 2 in transferrin-bound iron uptake in human hepatoma cells.	TF TFR2 TFRC	8.18e-08	3	152	3	19828835
Pubmed	Transferrin and transferrin receptors update.	TF TFR2 TFRC	8.18e-08	3	152	3	29969719
Pubmed	Transferrin Receptors TfR1 and TfR2 Bind Transferrin through Differing Mechanisms.	TF TFR2 TFRC	8.18e-08	3	152	3	29388418
Pubmed	Aluminum exposure affects transferrin-dependent and -independent iron uptake by K562 cells.	TF TFR2 TFRC	8.18e-08	3	152	3	16085060
Pubmed	Absence of binding between the human transferrin receptor and the transferrin complex of biological toxic trace element, aluminum, because of an incomplete open/closed form of the complex.	TF TFR2 TFRC	8.18e-08	3	152	3	19859668
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	CUL1 ABCF1 MYO6 PLEKHG4 RPAP3 SPTAN1 BAG2 MYO1B TFRC CSDE1 ACSL4 CSE1L SEC24C DDX50 SUGP2 MAGED2 P4HB MCM3AP AP3D1 TOP2B AQR HSP90AB1	1.16e-07	1353	152	22	29467282
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	ABCF1 USP9X SYNE1 BAG2 NCBP1 MYO1B UFL1 TFRC CSE1L SEC24C DDX50 SUGP2 P4HB SPEN FYN TOP2B PCM1 AQR HSP90AB1	1.25e-07	1024	152	19	24711643
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	CACNB4 ABCF1 USP9X SPTAN1 CNTNAP1 BAG2 CAMSAP3 PSD3 ZNFX1 ADAM22 RUFY3 CSDE1 CDKL5 CSE1L SUGP2 P4HB RABGEF1 PCM1 IGSF3 HSP90AB1	1.37e-07	1139	152	20	36417873
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	SEMA4D PDE3B MYO6 KSR2 NUCB2 CAMSAP3 CHD9 FOXN3 ADGRV1 RXRA ADGRG6 DNAH1 CSDE1 ANKRD44 PPP3CA THRB DENND1B SUGP2 PPIE ANKRD12 PATJ ZNF107 PCM1	1.45e-07	1489	152	23	28611215
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	ABCA3 MYO6 USP9X BAG2 NCBP1 MYO1B TFRC FANCD2 DDX50 MAGED2 SPEN	1.48e-07	313	152	11	38270169
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	NUP50 HAUS6 SYNE1 GATM TF DSN1 IKBIP TFRC CSDE1 RMDN3 P4HB ZNF644 SGO2 PPIE FYN TOP2B PCM1 AQR KNL1 WDTC1	1.72e-07	1155	152	20	20360068
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	ABCF1 USP9X SPTAN1 NCBP1 MYO1B LCP1 CSDE1 CSE1L SEC24C SUGP2 P4HB MCM3AP SPEN PCM1 AQR	2.03e-07	653	152	15	22586326
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	HAUS6 ABCF1 RAPGEF6 RPAP3 SPTAN1 TFRC CSDE1 AP3D1 PCM1 KNL1	2.10e-07	256	152	10	33397691
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CACNB4 USP9X SYNE1 SPTAN1 CNTNAP1 KSR2 CAMSAP3 ZNFX1 ADAM22 TDRD3 FRY PPP3CA AKAP9 SEC24C MAGED2 RABGEF1 PCM1 HSP90AB1	2.47e-07	963	152	18	28671696
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ABCF1 RAPGEF6 SPTAN1 TBC1D2 CAMSAP3 UFL1 MED1 FANCD2 SEC24C SUGP2 MAGED2 ZNF644 SPEN TOP2B PCM1 HSP90AB1	3.21e-07	774	152	16	15302935
Pubmed	Comparison of the interactions of transferrin receptor and transferrin receptor 2 with transferrin and the hereditary hemochromatosis protein HFE.	TF TFR2 TFRC	3.26e-07	4	152	3	11027676
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	HAUS6 MYO6 RUFY3 CDKL5 DNASE2B PPP3CA SEC24C DDX50 SUGP2 MAGED2 FLRT2 SPEN PCDH10 AP3D1 PCM1 IGSF3	3.37e-07	777	152	16	35844135
Pubmed	SENP3 regulates the global protein turnover and the Sp1 level via antagonizing SUMO2/3-targeted ubiquitination and degradation.	CUL1 NCBP1 UFL1 TFRC CSDE1 HSP90AB1	3.84e-07	64	152	6	26511642
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	CUL1 ABCA2 ABCF1 SYNE1 SPTAN1 NCBP1 MYO1B ZZEF1 DNAH1 TFRC RMDN3 CSE1L AKAP9 P4HB AP3D1 HSP90AB1	5.57e-07	807	152	16	30575818
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	NPC1 CUL1 MYO6 ERO1A CNTNAP1 IKBIP ADGRG6 TFR2 TFRC CSE1L P4HB UGGT2 IGSF3 HSP90AB1	5.64e-07	613	152	14	22268729
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	CUL1 ABCF1 MYO6 SPTAN1 BAG2 CHD9 NCBP1 MYO1B MED1 RXRA DNAH1 CSE1L AKAP9 SEC24C P4HB PPIE PATJ FYN AQR HSP90AB1	5.72e-07	1247	152	20	27684187
Pubmed	A quantitative chaperone interaction network reveals the architecture of cellular protein homeostasis pathways.	RPAP3 USP9X KSR2 BAG2 SLC34A2 SEC24C MAGED2 DNAAF10 NUDCD1 FYN HSP90AB1	6.42e-07	363	152	11	25036637
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	RAPGEF6 USP9X SPTAN1 BAG2 SH3GLB2 RUFY3 ANKRD44 AKAP9 DNAAF10 RABGEF1 PATJ PCM1	6.89e-07	446	152	12	24255178
Pubmed	DNA sequence and analysis of human chromosome 9.	SEMA4D HAUS6 SPTAN1 SH3GLB2 NCBP1 FREM1 ALG2 SPATA31D3 SHOC1 RBM18 TXNDC8	7.74e-07	370	152	11	15164053
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	NUP50 HAUS6 ABCF1 RAPGEF6 MYO6 RPAP3 MYO1B MED1 CSDE1 TDRD3 DDX50 SUGP2 AP3D1 TOP2B PCM1 KNL1 HSP90AB1	7.86e-07	934	152	17	33916271
Pubmed	HFE association with transferrin receptor 2 increases cellular uptake of transferrin-bound iron.	TF TFR2 TFRC	8.13e-07	5	152	3	18353247
Pubmed	METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis.	ABCF1 SPTAN1 BAG2 NCBP1 UFL1 TFRC CSDE1 MAGED2 TOP2B	8.86e-07	231	152	9	36597993
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	PDE3B TBC1D2 CAMSAP3 NCBP1 CPT1B CSMD2 ZZEF1 TDRD3 FRY SAMD9L LOXHD1 MCM3AP PCDH10 RBM41 HSP90AB1	9.12e-07	736	152	15	29676528
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	HAUS6 RAPGEF6 RPAP3 USP9X SPTAN1 TWF2 MED1 CSDE1 SUGP2 TET1 PATJ SPEN PCM1	9.76e-07	549	152	13	38280479
Pubmed	USP45 and Spindly are part of the same complex implicated in cell migration.	CUL1 USP9X SPTAN1 VPS13D CSE1L P4HB SGO2 PCM1 HSP90AB1	1.02e-06	235	152	9	30258100
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	ABCF1 SYNE1 SPTAN1 CHD9 NCBP1 MYO1B UFL1 MED1 CSE1L SEC24C DDX50 SUGP2 P4HB SPEN AP3D1 TOP2B AQR HSP90AB1	1.32e-06	1082	152	18	38697112
Pubmed	A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export.	NPC1 CUL1 USP9X BAG2 NCBP1 MYO1B ACSL4 CSE1L SEC24C FYN RAB4A	1.36e-06	392	152	11	33144569
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	SYNE1 SPTAN1 NUCB2 CAMSAP3 CC2D1B NCBP1 MYO1B LCP1 ALG2 TFRC ACSL4 DDX50 MAGED2 P4HB PCDHGB4 MYH15 UGGT2 SPEN AP3D1 TOP2B HSP90AB1	1.37e-06	1442	152	21	35575683
Pubmed	Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors.	USP9X CSE1L DDX50 MAGED2 P4HB PCM1 HSP90AB1	1.37e-06	125	152	7	36030824
Pubmed	Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.	NUP50 MYO6 RPAP3 SYNE1 BAG2 MYO1B TFRC FANCD2 ANKRD44 CSE1L P4HB DNAAF10 HSP90AB1	1.57e-06	573	152	13	28330616
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	HAUS6 TBC1D2 MCM3AP ARHGAP29 ANKRD12 NUDCD1 SPEN PCM1	1.61e-06	184	152	8	32908313
Pubmed	Myo6 facilitates the translocation of endocytic vesicles from cell peripheries.	MYO6 TF TFRC	1.62e-06	6	152	3	12857860
Pubmed	The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding.	TF TFR2 TFRC	1.62e-06	6	152	3	9465039
Pubmed	LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion.	ABCF1 ERO1A MYO1B LCP1 TF TFRC CSDE1 CSE1L P4HB TOP2B	1.94e-06	327	152	10	31409639
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	NPC1 NUP50 ABCF1 USP9X ERO1A BAG2 SH3GLB2 NCBP1 TWF2 IKBIP TFRC CSDE1 ACSL4 RMDN3 HIBCH MAGED2 P4HB NUDCD1 KNL1 HSP90AB1	2.34e-06	1367	152	20	32687490
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	CUL1 MYO6 SPTAN1 NCBP1 MYO1B MED1 IKBIP CSDE1 ACSL4 CSE1L AKAP9 SEC24C SUGP2 MAGED2 P4HB MCM3AP AP3D1 PCM1 DUSP11 HSP90AB1	2.44e-06	1371	152	20	36244648
Pubmed	The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA.	CUL1 MYO6 BAG2 NCBP1 ACSL4 CSE1L MAGED2 P4HB AP3D1	2.50e-06	262	152	9	36880596
Pubmed	PRIC320, a transcription coactivator, isolated from peroxisome proliferator-binding protein complex.	CHD9 MED1 RXRA	2.83e-06	7	152	3	16554032
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	HAUS6 ABCF1 RAPGEF6 RPAP3 USP9X NCBP1 ZNFX1 CSDE1 DENND1B SEC24C MAGED2 DNAAF10 MCM3AP ARHGAP29 UVRAG AP3D1 WDTC1	3.26e-06	1038	152	17	26673895
Pubmed	Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.	SYNE1 SPTAN1 NCBP1 TFRC CSE1L DDX50 SUGP2 MAGED2 P4HB PPIE AP3D1 TOP2B AQR HSP90AB1	3.35e-06	714	152	14	28302793
Pubmed	Defining the membrane proteome of NK cells.	NPC1 PDE3B ABCA2 ABCF1 MYO6 USP9X ERO1A MED1 IKBIP ALG2 ACSL4 CSE1L DDX50 MAGED2 AP3D1 PCM1 AQR HSP90AB1	3.83e-06	1168	152	18	19946888
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	HAUS6 DSN1 SUGP2 SGO2 TOP2B PCM1 KNL1 HSP90AB1	4.31e-06	210	152	8	16565220
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	USP9X BAG2 CHD9 SUGP2 MAGED2 ZNF644 SGO2 SPEN KNL1	4.55e-06	282	152	9	23667531
Pubmed	Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.	NUP50 MYO6 RPAP3 BAG2 CAMSAP3 MYO1B DSN1 CDKL5 DNAAF10 KNL1	4.67e-06	361	152	10	30344098
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	TBX4 MYO6 USP9X ZNFX1 MED1 CSMD2 ADCY2 DSN1 ACSL4 SPEN RAB4A IGSF3 KNL1	5.04e-06	638	152	13	31182584
Pubmed	ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.	CUL1 ABCF1 NCBP1 UFL1 TFRC CSDE1 CSE1L THRB DDX50 ZNF107 HSP90AB1	5.20e-06	451	152	11	36168627
Pubmed	The E3 ubiquitin ligase FBXL6 controls the quality of newly synthesized mitochondrial ribosomal proteins.	CUL1 NUP50 ABCF1 RPAP3 USP9X BAG2 DDX50 SUGP2 MAGED2 DNAAF10 AP3D1 HSP90AB1	5.63e-06	547	152	12	37267103
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	CUL1 KIF27 PLEKHG4 CENPO UFL1 FOXN3 RXRA IKBIP ACSL4 RMDN3 SUGP2 ZNF644 SPEN TOP2B HSP90AB1	5.81e-06	857	152	15	25609649
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	PDE3B RAPGEF6 SPTAN1 CAMSAP3 PSD3 FSIP2 VPS13D DENND1B AKAP9 TET1 RABGEF1 PATJ UVRAG PCM1 AQR	6.15e-06	861	152	15	36931259
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	PDE3B ABCF1 RAPGEF6 RPAP3 CAMSAP3 CC2D1B ZNFX1 ZZEF1 CSDE1 UGGT2 PATJ AP3D1 AQR	6.15e-06	650	152	13	38777146
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	CUL1 NUP50 ABCA2 ABCF1 MYO6 RPAP3 USP9X BAG2 NCBP1 FANCD2 CSDE1 CSE1L PPP3CA SEC24C MAGED2 P4HB DNAAF10 PPIE HSP90AB1	6.33e-06	1335	152	19	29229926
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	USP9X SPTAN1 CAMSAP3 PSD3 UFL1 TF TDRD3 FRY AP3D1 TOP2B PCM1	8.46e-06	475	152	11	31040226
Pubmed	HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways.	CUL1 USP9X BAG2 IKBIP TFRC FANCD2 CSDE1 CSE1L MAGED2 PATJ WDTC1 HSP90AB1	8.67e-06	571	152	12	37167062
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	CUL1 PDE3B MYO6 RPAP3 SYNE1 BAG2 SH3GLB2 UFL1 ZZEF1 FANCD2 ACSL4 RMDN3 TDRD3 VPS13D AKAP9 DDX50 HIBCH MAGED2 DNAAF10 ZNF644	8.90e-06	1496	152	20	32877691
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	CUL1 NUP50 IFT140 RPAP3 ZNF644 KNL1 DUSP11 WDTC1	8.93e-06	232	152	8	25515538
Pubmed	A forward genetics screen in mice identifies recessive deafness traits and reveals that pejvakin is essential for outer hair cell function.	MYO6 ADGRV1 LOXHD1	9.60e-06	10	152	3	17329413
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	ABCF1 MYO6 USP9X SPTAN1 BAG2 CAMSAP3 MYO1B LCP1 TFRC CSE1L MAGED2 P4HB DNAAF10 PATJ AP3D1 WDTC1 HSP90AB1	1.23e-05	1149	152	17	35446349
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	CUL1 ABCF1 MYO6 USP9X BAG2 CAMSAP3 CHD9 LCP1 VPS13D LOXHD1 AP3D1	1.29e-05	497	152	11	36774506
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	ABCF1 USP9X APAF1 GATM MYO1B RUFY3 SEC24C SUGP2 MAGED2 FYN AQR	1.31e-05	498	152	11	36634849
Pubmed	Identification of proteins associated with ligand-activated estrogen receptor α in human breast cancer cell nuclei by tandem affinity purification and nano LC-MS/MS.	MYO6 SPTAN1 MYO1B TF TFRC VPS13D DDX50 TOP2B	1.33e-05	245	152	8	21182205
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	ABCF1 SYNE1 NCBP1 ZNFX1 PCDH20 CSDE1 TDRD3 DDX50 SUGP2 P4HB SPEN AQR DUSP11 HSP90AB1	1.33e-05	807	152	14	22681889
Pubmed	A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.	ERO1A SPTAN1 MYO1B UFL1 IKBIP CSDE1 CSE1L AKAP9 P4HB AP3D1 RBM41	1.44e-05	503	152	11	36217030
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	NPC1 CACNB4 RAPGEF5 SPTAN1 SH3GL3 CENPO UFL1 FOXN3 MED1 RUFY3 CSDE1 THRB DENND1B HIBCH DNAAF10 ANKRD12 PCM1 DUSP11	1.52e-05	1293	152	18	15342556
Pubmed	Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis.	TF TFR2 TFRC	1.75e-05	12	152	3	25352340
Pubmed	Identification of epilepsy genes in human and mouse.	CACNB4 ADGRV1 AP3D1	1.75e-05	12	152	3	11700294
Pubmed	Molecular mechanisms involved in the actions of apotransferrin upon the central nervous system: Role of the cytoskeleton and of second messengers.	TF TFRC	1.90e-05	2	152	2	12210842
Pubmed	Novel pathway for iron deficiency in pediatric non-alcoholic steatohepatitis.	TF TFR2	1.90e-05	2	152	2	25000850
Pubmed	Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.	TFR2 TFRC	1.90e-05	2	152	2	15987753
Pubmed	Computational structure models of apo and diferric transferrin-transferrin receptor complexes.	TF TFRC	1.90e-05	2	152	2	19838776
Pubmed	A novel transferrin receptor-targeted hybrid peptide disintegrates cancer cell membrane to induce rapid killing of cancer cells.	TFR2 TFRC	1.90e-05	2	152	2	21849092
Pubmed	Structural mechanism for signal transduction in RXR nuclear receptor heterodimers.	RXRA THRB	1.90e-05	2	152	2	26289479
Pubmed	A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease.	TF TFR2	1.90e-05	2	152	2	19250966
Pubmed	Mutational analysis of C-lobe ligands of human serum transferrin: insights into the mechanism of iron release.	TF TFRC	1.90e-05	2	152	2	15924420
Pubmed	Identification of 96 single nucleotide polymorphisms in eight genes involved in iron metabolism: efficiency of bioinformatic extraction compared with a systematic sequencing approach.	TF TFRC	1.90e-05	2	152	2	11702220
Pubmed	The mechanism of iron release from the transferrin-receptor 1 adduct.	TF TFRC	1.90e-05	2	152	2	16564538
Pubmed	Calcineurin dephosphorylates topoisomerase IIβ and regulates the formation of neuronal-activity-induced DNA breaks.	PPP3CA TOP2B	1.90e-05	2	152	2	36206766
Pubmed	Noncanonical interactions between serum transferrin and transferrin receptor evaluated with electrospray ionization mass spectrometry.	TF TFRC	1.90e-05	2	152	2	20404192
Pubmed	Complexation of ytterbium to human transferrin and its uptake by K562 cells.	TF TFRC	1.90e-05	2	152	2	12473103
Pubmed	A loop in the N-lobe of human serum transferrin is critical for binding to the transferrin receptor as revealed by mutagenesis, isothermal titration calorimetry, and epitope mapping.	TF TFRC	1.90e-05	2	152	2	19693784
Pubmed	Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor.	TF TFRC	1.90e-05	2	152	2	23650374
Pubmed	Molecular cloning of novel Monad binding protein containing tetratricopeptide repeat domains.	RPAP3 DNAAF10	1.90e-05	2	152	2	18538670
Pubmed	Physical characterization of the transferrin receptor in human placentae.	TF TFRC	1.90e-05	2	152	2	6268632
Pubmed	Theoretical study of molecular mechanism of binding TRAP220 coactivator to Retinoid X Receptor alpha, activated by 9-cis retinoic acid.	MED1 RXRA	1.90e-05	2	152	2	20398753
Pubmed	Diferric transferrin regulates transferrin receptor 2 protein stability.	TF TFR2	1.90e-05	2	152	2	15319290
Interaction	CDC42 interactions	NPC1 CUL1 PDE3B MYO6 PLEKHG4 USP9X SYNE1 SPTAN1 KSR2 PSD3 SH3GLB2 UFL1 TFRC FANCD2 ACSL4 CSE1L SEC24C DDX50 MCM3AP ARHGAP29 FLRT2 FYN RAB4A AP3D1 LRIF1 TOP2B PCM1 IGSF3	3.92e-07	1323	149	28	int:CDC42
Interaction	RAC2 interactions	CUL1 PDE3B MYO6 PLEKHG4 USP9X SPTAN1 PSD3 MYO1B UFL1 ADAM22 ADGRG6 TFRC FANCD2 RMDN3 VPS13D DDX50 FLRT2 FYN IGSF3	5.92e-07	674	149	19	int:RAC2
Interaction	GABRA1 interactions	USP9X CDKL5 CSE1L PPP3CA DDX50 MAGED2 P4HB PCM1 HSP90AB1	1.98e-06	152	149	9	int:GABRA1
Interaction	CIT interactions	NUP50 HAUS6 ABCF1 KIF27 MYO6 RPAP3 SYNE1 SPTAN1 BAG2 NCBP1 MYO1B ADGRV1 MED1 ZZEF1 TFRC ACSL4 CSE1L AKAP9 SEC24C DDX50 SUGP2 MAGED2 P4HB PATJ ZNF107 TOP2B AQR HSP90AB1	2.40e-06	1450	149	28	int:CIT
Interaction	SENP3 interactions	CUL1 PLEKHG4 NCBP1 UFL1 TFRC CSDE1 SUGP2 MAGED2 MCM3AP MED25 TOP2B HSP90AB1	2.54e-06	301	149	12	int:SENP3
Interaction	ARRDC4 interactions	ABCA3 MYO6 BAG2 MYO1B TFRC FANCD2 MAGED2	2.72e-06	83	149	7	int:ARRDC4
Interaction	TRIM37 interactions	HAUS6 KIF27 MYO6 SPTAN1 BAG2 TBC1D2 MYO1B THRB P4HB MCM3AP ARHGAP29 ANKRD12 NUDCD1 SPEN PCM1 WDTC1 HSP90AB1	4.35e-06	630	149	17	int:TRIM37
Interaction	KCNA3 interactions	HAUS6 MYO6 RPAP3 USP9X BAG2 PSD3 CHD9 CC2D1B MYO1B TFRC CSDE1 CSE1L SEC24C MAGED2 ARHGAP29 PATJ SPEN FYN AP3D1 HSP90AB1	6.73e-06	871	149	20	int:KCNA3
Interaction	CSDE1 interactions	CUL1 BAG2 NCBP1 UFL1 ZNFX1 GRAMD4 FANCD2 CSDE1 TDRD3 SEC24C WDTC1	8.87e-06	284	149	11	int:CSDE1
Interaction	NR3C1 interactions	TBX4 MYO6 USP9X BAG2 CHD9 ZNFX1 MED1 CSMD2 TF ADCY2 DSN1 TFRC ACSL4 MED25 SPEN FYN RAB4A LRIF1 IGSF3 KNL1 HSP90AB1	1.01e-05	974	149	21	int:NR3C1
Interaction	KCTD13 interactions	CACNB4 ABCF1 MYO6 USP9X SYNE1 SPTAN1 CNTNAP1 BAG2 CAMSAP3 PSD3 TWF2 ZNFX1 TF ADAM22 ALG2 RUFY3 CSDE1 CDKL5 CSE1L PPP3CA SEC24C SUGP2 P4HB AP3D1 PCM1 HSP90AB1	1.08e-05	1394	149	26	int:KCTD13
Interaction	CTSS interactions	MYO6 ERO1A SPTAN1 BAG2 NUCB2 MYO1B IKBIP UGGT2	1.25e-05	145	149	8	int:CTSS
Interaction	NPAS1 interactions	IFT140 HAUS6 PLEKHG4 BAG2 APAF1 PSD3 DSN1 MAGED2 KNL1 HSP90AB1	1.46e-05	245	149	10	int:NPAS1
Interaction	SCYL2 interactions	SH3GL3 BAG2 UFL1 TFRC FANCD2 RMDN3 AKAP9 SPEN RAB4A	1.50e-05	195	149	9	int:SCYL2
Interaction	PML interactions	CUL1 NUP50 MYO6 RPAP3 BAG2 NCBP1 MED1 DSN1 RXRA FANCD2 CSDE1 ACSL4 CSE1L DDX50 MAGED2 P4HB AP3D1 TOP2B KNL1 HSP90AB1	1.83e-05	933	149	20	int:PML
Interaction	ZNF830 interactions	NUP50 MCM3AP PPIE RAB4A PCM1 AQR	2.11e-05	76	149	6	int:ZNF830
Interaction	RHOA interactions	NPC1 PDE3B MYO6 PLEKHG4 USP9X SPTAN1 CNTNAP1 SH3GLB2 UFL1 ADGRG6 TFRC FANCD2 ACSL4 VPS13D CSE1L DDX50 ARHGAP29 PPIE FLRT2 PATJ FYN TOP2B IGSF3	2.41e-05	1199	149	23	int:RHOA
Interaction	TNIK interactions	CACNB4 USP9X ERO1A SYNE1 SPTAN1 BAG2 CDKL5 TDRD3 AKAP9 SEC24C MAGED2 PCM1	2.72e-05	381	149	12	int:TNIK
Interaction	NR1I3 interactions	NPC1 CHD9 MED1 RXRA HSP90AB1	2.74e-05	48	149	5	int:NR1I3
Interaction	MKRN2 interactions	SEMA4D MYO6 FZD3 APAF1 UFL1 CSDE1 TDRD3 HIBCH FYN AP3D1 TOP2B WDTC1	3.01e-05	385	149	12	int:MKRN2
Interaction	YWHAZ interactions	CUL1 PDE3B RAPGEF6 ERO1A SPTAN1 KSR2 CAMSAP3 PSD3 UFL1 ADAM22 FANCD2 FSIP2 RMDN3 VPS13D PPP3CA DENND1B AKAP9 ZNF644 ARHGAP29 RABGEF1 PPIE UVRAG PCM1 HSP90AB1	3.69e-05	1319	149	24	int:YWHAZ
Interaction	PHLPP1 interactions	HAUS6 ABCF1 RAPGEF6 RPAP3 SPTAN1 BAG2 TFRC CSDE1 AP3D1 PCM1 KNL1	3.86e-05	333	149	11	int:PHLPP1
Interaction	YWHAG interactions	PDE3B RAPGEF6 RPAP3 SPTAN1 KSR2 CAMSAP3 PSD3 FANCD2 RMDN3 VPS13D CSE1L DENND1B AKAP9 P4HB TET1 ARHGAP29 RABGEF1 PPIE PATJ UVRAG PCM1 AQR HSP90AB1	4.50e-05	1248	149	23	int:YWHAG
Interaction	MIS12 interactions	CAMSAP3 TF DSN1 ZNF644 LRIF1 KNL1	5.18e-05	89	149	6	int:MIS12
Interaction	STIP1 interactions	CUL1 RPAP3 USP9X SPTAN1 BAG2 SH3GLB2 NCBP1 UFL1 TFRC FANCD2 CSDE1 TDRD3 CSE1L SEC24C SUGP2 MAGED2 P4HB AP3D1 TOP2B HSP90AB1	5.30e-05	1006	149	20	int:STIP1
Interaction	CPT1B interactions	CPT1B FANCD2 THRB	8.30e-05	12	149	3	int:CPT1B
Interaction	EEF1AKMT3 interactions	IFT140 HAUS6 PLEKHG4 BAG2 APAF1 PSD3 MYO1B ARHGAP29 PATJ AQR HSP90AB1	8.59e-05	364	149	11	int:EEF1AKMT3
Interaction	STIL interactions	CUL1 RPAP3 USP9X BAG2 FANCD2 AKAP9 SEC24C PCM1	8.64e-05	190	149	8	int:STIL
Interaction	NAA11 interactions	HAUS6 PLEKHG4 APAF1 DSN1 KNL1	9.52e-05	62	149	5	int:NAA11
Interaction	PRC1 interactions	HAUS6 ABCF1 SYNE1 SPTAN1 BAG2 NCBP1 ZZEF1 AKAP9 SEC24C DDX50 P4HB DNAAF10 PPIE PATJ SPEN TOP2B PCM1 AQR HSP90AB1	1.05e-04	973	149	19	int:PRC1
Interaction	RPRD2 interactions	NUP50 MYO6 RPAP3 BAG2 NCBP1 MED1 DNAAF10	1.08e-04	146	149	7	int:RPRD2
Interaction	VPS33B interactions	CAMSAP3 TFRC RMDN3 TDRD3 RAB4A UVRAG AP3D1 PCM1	1.19e-04	199	149	8	int:VPS33B
Interaction	RICTOR interactions	CUL1 HAUS6 ABCF1 MYO6 RAPGEF5 USP9X BAG2 SH3GLB2 TFRC FANCD2 ACSL4 CDKL5 SEC24C SUGP2 P4HB HSP90AB1	1.62e-04	759	149	16	int:RICTOR
Interaction	LMNB1 interactions	NUP50 USP9X SPTAN1 UFL1 ZZEF1 RXRA TFRC FANCD2 CSE1L PPP3CA DDX50 MCM3AP RAB4A AQR	1.78e-04	610	149	14	int:LMNB1
Interaction	YWHAB interactions	PDE3B RAPGEF6 RPAP3 SPTAN1 KSR2 CAMSAP3 PSD3 ADAM22 FANCD2 RMDN3 VPS13D DENND1B AKAP9 P4HB RABGEF1 PPIE UVRAG PCM1 HSP90AB1	1.78e-04	1014	149	19	int:YWHAB
Interaction	YWHAH interactions	PDE3B ABCA2 RAPGEF6 SPTAN1 KSR2 CAMSAP3 PSD3 MED1 FANCD2 RMDN3 VPS13D DENND1B AKAP9 TET1 RABGEF1 PATJ UVRAG PCM1 AQR HSP90AB1	1.82e-04	1102	149	20	int:YWHAH
Interaction	RHOBTB2 interactions	MYO6 USP9X NCBP1 CSE1L TOP2B AQR HSP90AB1	2.30e-04	165	149	7	int:RHOBTB2
Interaction	MAP2K2 interactions	HAUS6 KSR2 BAG2 ZNFX1 CSE1L MAGED2 P4HB MCM3AP HSP90AB1	2.31e-04	278	149	9	int:MAP2K2
Interaction	PPARD interactions	IFT140 APAF1 RXRA MCM3AP SPEN KNL1	2.35e-04	117	149	6	int:PPARD
Interaction	SAMD3 interactions	FANCD2 AKAP9 SUGP2	2.50e-04	17	149	3	int:SAMD3
Interaction	HNRNPC interactions	CUL1 MYO6 SPTAN1 NCBP1 UFL1 MED1 FANCD2 AKAP9 DDX50 SUGP2 PPIE AQR RBM41 DUSP11	2.64e-04	634	149	14	int:HNRNPC
Interaction	ARHGAP24 interactions	CUL1 ABCF1 NCBP1 UFL1 TFRC CSDE1 CSE1L THRB DDX50 ZNF107 WDTC1 HSP90AB1	2.71e-04	486	149	12	int:ARHGAP24
Interaction	TUBB4B interactions	CUL1 USP9X CAMSAP3 EML2 UFL1 ADAM22 FANCD2 CSE1L THRB MAGED2 ARHGAP29 PCM1 HSP90AB1	2.73e-04	560	149	13	int:TUBB4B
Interaction	CAPZB interactions	MYO6 RPAP3 SPTAN1 BAG2 NUCB2 NCBP1 MYO1B TWF2 UFL1 LCP1 TFRC FANCD2 CSDE1 SGO2 PATJ RAB4A TOP2B PCM1 HSP90AB1	2.74e-04	1049	149	19	int:CAPZB
Interaction	GRIN2B interactions	SPTAN1 PSD3 CDKL5 PPP3CA AKAP9 PATJ FYN	2.76e-04	170	149	7	int:GRIN2B
Interaction	FBXO6 interactions	NPC1 CUL1 ABCA2 MYO6 ERO1A CNTNAP1 IKBIP ADGRG6 TFR2 TFRC CSE1L P4HB UGGT2 IGSF3 HSP90AB1	2.83e-04	717	149	15	int:FBXO6
Interaction	LRRIQ1 interactions	KIF27 ACVR2A FYN HSP90AB1	2.83e-04	43	149	4	int:LRRIQ1
Interaction	TFRC interactions	MYO6 ERO1A SPTAN1 BAG2 NUCB2 TF TFR2 TFRC FANCD2 RMDN3 MYH15 RAB4A	2.86e-04	489	149	12	int:TFRC
Interaction	DNAJB11 interactions	ERO1A BAG2 NUCB2 IKBIP TFRC FANCD2 SEC24C P4HB UGGT2 WDTC1	2.90e-04	351	149	10	int:DNAJB11
Interaction	CD79B interactions	PDE3B ABCA3 MANEA ALG2 FANCD2 FYN	2.95e-04	122	149	6	int:CD79B
Cytoband	9q21.32	KIF27 SPATA31D4 SPATA31D3	3.32e-05	19	152	3	9q21.32
Cytoband	3p24	LRRC3B TOP2B	3.01e-04	8	152	2	3p24
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	CUL1 USP9X PSD3 CHD9 MYO1B FOXN3 MED1 ZZEF1 ADGRG6 ACSL4 TDRD3 CSE1L AKAP9 ARHGAP29 FLRT2 SPEN FYN UVRAG AQR	5.28e-07	856	151	19	M4500
Coexpression	GSE14308_TH1_VS_INDUCED_TREG_UP	CUL1 CACNB4 ACVR2A TF TDRD3 SGO2 ANKRD12 LRIF1 KNL1	2.54e-06	200	151	9	M3378
Coexpression	GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP	NUP50 CHD9 TWF2 LCP1 GRAMD4 RXRA TOP2B PCM1 AQR	2.54e-06	200	151	9	M3277
Coexpression	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	NUP50 HAUS6 RPAP3 ERO1A MANEA DSN1 IKBIP TFRC FANCD2 CSE1L ZNF644 SGO2 UGGT2 LRIF1 KNL1	5.06e-06	644	151	15	M10501
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	SYCP2L CACNB4 ABCA3 RAPGEF6 ENOX1 RAPGEF5 KSR2 FOXN3 ACVR2A CSMD2 RUFY3 FSIP2 ACSL4 ANKRD44 FRY AKAP9 SUGP2 LRRC3B ANKRD12 IGSF3	5.95e-06	1106	151	20	M39071
Coexpression	ENK_UV_RESPONSE_EPIDERMIS_DN	SEMA4D MYO6 SPTAN1 GATM SH3GLB2 EML2 FOXN3 TFRC FRY PPP3CA ARHGAP29 FYN UVRAG	8.95e-06	512	151	13	M4508
Coexpression	GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_UP	NUP50 CACNB4 ABCF1 BAG2 ADCY2 PPP3CA SPEN RAB4A	2.11e-05	199	151	8	M8429
Coexpression	LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX	PSD3 FREM1 RUFY3 PPP3CA THRB AKAP9 SHOC1	2.95e-05	152	151	7	M39239
Coexpression	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN	CUL1 SEMA4D PDE3B FZD3 BAG2 GATM MED1 LCP1 CSDE1 MCM3AP PPIE RAB4A HSP90AB1	3.93e-05	590	151	13	M16066
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	SEMA4D HAUS6 RAPGEF6 USP9X SYNE1 SPTAN1 TWF2 ZNFX1 MED1 LCP1 CSDE1 ACSL4 ANKRD44 SAMD9L DENND1B TC2N AKAP9 ZNF644 SPEN FYN TOP2B PCM1	4.66e-05	1492	151	22	M40023
Coexpression	GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN	NAA60 AKAP9 MCM3AP TET1 SPEN RAB4A PCM1	4.79e-05	164	151	7	M8989
Coexpression	AKL_HTLV1_INFECTION_DN	UFL1 FRY DENND1B AKAP9 FYN	4.96e-05	69	151	5	M9815
Coexpression	GSE4984_GALECTIN1_VS_LPS_STIM_DC_DN	SEMA4D SYCP2L FANCD2 CSE1L P4HB FYN HSP90AB1	5.79e-05	169	151	7	M6504
Coexpression	GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_UP	RAPGEF6 PSD3 TET1 KCNMB3 PATJ TOP2B PCM1	6.24e-05	171	151	7	M2947
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	CUL1 USP9X CHD9 MYO1B FOXN3 ADGRG6 AKAP9 ARHGAP29 SPEN FYN UVRAG	8.60e-05	466	151	11	M13522
Coexpression	GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN	RAPGEF6 PSD3 LCP1 ANKRD44 FRY SLC9C1 PPP3CA	9.55e-05	183	151	7	M8189
Coexpression	NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN	SYNE1 APAF1 PSD3 ACVR2A MED1 RUFY3 TFRC RABGEF1 FYN RAB4A	1.11e-04	399	151	10	M40939
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	HAUS6 RAPGEF6 MYO6 RPAP3 USP9X NUCB2 UFL1 TDRD3 ZNF644 ZNF107 TOP2B PCM1 KNL1	1.14e-04	656	151	13	M18979
Coexpression	GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP	LCP1 ADCY2 FREM1 TFR2 P4HB SERPINA10 RAB4A	1.37e-04	194	151	7	M8674
Coexpression	GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_UP	IKBIP ALG2 CSE1L ZNF644 SGO2 KNL1 DUSP11	1.46e-04	196	151	7	M3280
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HDA1	RAPGEF5 KSR2 ACVR2A CSMD2 ADCY2 ADAM22 RUFY3 ACSL4 ANKRD44 FRY AKAP9 LRRC3B	1.51e-04	584	151	12	M39068
Coexpression	GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_DN	CUL1 NUP50 USP9X TDRD3 RAB4A UVRAG LRIF1	1.56e-04	198	151	7	M3248
Coexpression	GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN	CUL1 RPAP3 CHD9 RMDN3 DENND1B UVRAG AP3D1	1.66e-04	200	151	7	M3414
Coexpression	GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN	NUP50 ABCF1 MYO6 NCBP1 ADAM22 FYN DUSP11	1.66e-04	200	151	7	M8533
Coexpression	GSE17721_LPS_VS_POLYIC_8H_BMDC_UP	CUL1 NUP50 SYNE1 NCBP1 CSDE1 RABGEF1 RBM18	1.66e-04	200	151	7	M3811
Coexpression	GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDC_UP	NUP50 ABCF1 MED1 RUFY3 RMDN3 TRPM5 AP3D1	1.66e-04	200	151	7	M3883
Coexpression	GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN	NPC1 ERO1A TBC1D2 RXRA DDX50 P4HB RABGEF1	1.66e-04	200	151	7	M5338
Coexpression	GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_UP	NUP50 SEMA4D ZNFX1 RUFY3 AKAP9 AP3D1 HSP90AB1	1.66e-04	200	151	7	M9073
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#4_top-relative-expression-ranked_1000	NUP50 HAUS6 TBX4 RPAP3 APAF1 MYO1B IKBIP ANKRD44 SGO2 IGSF3	3.00e-06	214	150	10	gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k4
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#5_top-relative-expression-ranked_1000	RAPGEF6 MYO6 ADGRG6 TFRC SAMD9L DENND1B PATJ	2.21e-05	119	150	7	gudmap_developingKidney_e15.5_cortic collect duct_1000_k5
CoexpressionAtlas	facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1	PRRX1 SH3GL3 NUCB2 PSD3 GATM CHD9 ADCY2 ADAM22 IKBIP FREM1 ADGRG6 ANKRD44 CDKL5 TDRD3 TRPM5 MAGED2 ZNF644 TET1 UGGT2 ANKRD12 FLRT2 LRIF1	2.41e-05	1166	150	22	facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000	HAUS6 PRRX1 APAF1 PSD3 NCBP1 MYO1B IKBIP PCDH20 ANKRD44 TDRD3 SGO2 PCDH10 IGSF3	3.61e-05	478	150	13	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000	HAUS6 PRRX1 TBX4 PCDH20 ANKRD44 TDRD3 FLRT2 PCDH10 IGSF3	3.75e-05	229	150	9	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000_k1
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#1_top-relative-expression-ranked_500	RAPGEF6 ADGRG6 SAMD9L AKAP9 PATJ	3.94e-05	54	150	5	gudmap_developingKidney_e15.5_cortic collect duct_500_k1
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_1000	APAF1 ADCY2 FREM1 FANCD2 PPP3CA TET1 SGO2 UGGT2 FLRT2 AQR	6.78e-05	307	150	10	gudmap_developingKidney_e15.5_Peripheral blastema_1000_k3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	SYCP2L ABCA2 ABCF1 RPAP3 FZD3 CAMSAP3 NCBP1 MANEA ADGRV1 ACVR2A RXRA RUFY3 ACSL4 AKAP9 LRIF1 TOP2B PCM1 KNL1 HSP90AB1	7.18e-05	989	150	19	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_1000	PRRX1 SH3GL3 MANEA ADCY2 IKBIP FANCD2 SGO2 IGSF3	7.58e-05	195	150	8	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000	NUP50 HAUS6 TBX4 MYO6 RPAP3 APAF1 MYO1B IKBIP TFR2 ANKRD44 FRY MAGED2 SGO2 UGGT2 TOP2B AQR IGSF3	9.08e-05	837	150	17	gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	PDE3B ABCA2 ABCF1 FZD3 KSR2 CHD9 FOXN3 CPT1B RUFY3 FANCD2 CDKL5 CSE1L DENND1B AKAP9 ZNF644 SGO2 LRIF1 PCM1 KNL1	1.77e-04	1060	150	19	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	HAUS6 PDE3B PRRX1 USP9X CHD9 MYO1B UFL1 FREM1 CSE1L AKAP9 HIBCH ZNF644 TET1 SGO2 ANKRD12 NUDCD1 LRIF1 RBM18 TOP2B PCM1 KNL1	1.97e-04	1252	150	21	facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	NUP50 HAUS6 PDE3B ABCF1 FZD3 USP9X CHD9 UFL1 FANCD2 TDRD3 CSE1L DENND1B AKAP9 ZNF644 TET1 SGO2 NUDCD1 LRIF1 PCM1 KNL1 HSP90AB1	2.08e-04	1257	150	21	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000	HAUS6 APAF1 ADGRV1 ADCY2 GRAMD4 PCDH20 FREM1 FANCD2 PPP3CA TRPM5 TET1 SGO2 UGGT2 FLRT2 TOP2B AQR	2.29e-04	819	150	16	gudmap_developingKidney_e15.5_Peripheral blastema_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	NUP50 SYCP2L HAUS6 PDE3B ABCF1 FZD3 USP9X CHD9 UFL1 ADGRV1 FANCD2 TDRD3 CSE1L DENND1B AKAP9 ZNF644 TET1 SGO2 NUDCD1 LRIF1 PCM1 KNL1 HSP90AB1	2.36e-04	1459	150	23	facebase_RNAseq_e10.5_Emin_LatNas_2500
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	NPC1 PDE3B SYNE1 ANKRD44 TC2N AKAP9 SUGP2 ZNF644 ANKRD12 PCM1	1.78e-09	199	152	10	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	COPD-Epithelial-ATII\|World / Disease state, Lineage and Cell class	ABCA3 MYO6 RAPGEF5 SYNE1 SLC34A2 MYO1B ADGRV1 PATJ IGSF3	1.42e-08	183	152	9	8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ABCA3 MYO6 RAPGEF5 SLC34A2 ACSL4 SLC9C1 TC2N PATJ AP3D1	1.64e-08	186	152	9	acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e
ToppCell	Control\|World / group, cell type (main and fine annotations)	ABCA3 MYO6 RAPGEF5 SYNE1 MYO1B ADGRV1 SLC9C1 PATJ	1.19e-07	168	152	8	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PDE3B MYO6 SYNE1 GATM ADCY2 FRY LOXHD1 ARHGAP29	1.30e-07	170	152	8	f0b0d2d0402de3ed7322284a599646db43475761
ToppCell	368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PDE3B MYO6 SYNE1 GATM ADCY2 FRY LOXHD1 ARHGAP29	1.30e-07	170	152	8	054360a3b05f5e41221c98b122d241b1affad26a
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	SEMA4D PDE3B RAPGEF6 SYNE1 TFRC AKAP9 ANKRD12 PCM1	1.36e-07	171	152	8	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	PDE3B RAPGEF6 TFRC ANKRD44 TC2N ANKRD12 FYN PCM1	3.30e-07	192	152	8	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNB4 ABCA3 RAPGEF5 SLC34A2 ADGRV1 ACSL4 CDKL5 THRB	3.30e-07	192	152	8	cc9911e182a289779a2612bc213daae5607689e7
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SEMA4D ABCA2 RAPGEF5 SH3GL3 TF CDKL5 MYH15 PCDH10	3.30e-07	192	152	8	3ce5dbde41aeb73d49f2c7991d34682f0827fa5a
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNB4 ABCA3 MYO6 RAPGEF5 SYNE1 SLC34A2 ADGRV1 RUFY3	3.43e-07	193	152	8	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNB4 ABCA3 MYO6 RAPGEF5 SYNE1 SLC34A2 ADGRV1 RUFY3	3.43e-07	193	152	8	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NPC1 CACNB4 ABCA3 RAPGEF5 SYNE1 MYO1B ADGRV1 PATJ	3.57e-07	194	152	8	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ABCA3 MYO6 SYNE1 SLC34A2 MYO1B ADGRV1 SLC9C1 PATJ	3.71e-07	195	152	8	9406866f99555198a9be311fbd65751b70f35446
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NPC1 ABCA3 RAPGEF5 SYNE1 SLC34A2 ADGRV1 RUFY3 ACSL4	3.86e-07	196	152	8	7e5addaa844e66f8160e05858c341866a80aed23
ToppCell	mild-low-quality_cells\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	NPC1 PDE3B ABCA2 SYNE1 ADAM22 TFR2 TC2N SUGP2	4.01e-07	197	152	8	e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNB4 ABCA3 MYO6 SLC34A2 MYO1B ADGRV1 CDKL5 SLC9C1	4.33e-07	199	152	8	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	COVID-19-lung\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE3B ABCA3 TBC1D2 SLC34A2 LCP1 ANKRD44 SAMD9L HSP90AB1	4.33e-07	199	152	8	155b03b859157013e9142e9248551369127d9204
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE3B PRRX1 TBX4 ENOX1 SYNE1 COL6A5 FREM1 FLRT2	4.49e-07	200	152	8	58b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCell	Goblet-gob-2\|World / Class top	PDE3B SH3GL3 SLC34A2 MYO1B DYNLT2 ADCY2 RAB4A	5.93e-07	142	152	7	9b058dc313d1f0edcd8473e342852632e17536a6
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB4 PDE3B MYO6 MYO1B ADAM22 ACSL4 TRPM5	9.81e-07	153	152	7	9b6675ace8a83c8d446b722301d0ec4e6840f3fc
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Spp1_(Entopeduncular_Nucleus_(Ent)_or_Zona_Incerta,_ventral_part_(ZIV)._State_signal?)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	SYCP2L PLEKHG4 DNASE2B KCNMB3 DNAH9	1.14e-06	54	152	5	98b31718fa200432cf86b59a52484da101219f96
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Spp1_(Entopeduncular_Nucleus_(Ent)_or_Zona_Incerta,_ventral_part_(ZIV)._State_signal?)-\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	SYCP2L PLEKHG4 DNASE2B KCNMB3 DNAH9	1.14e-06	54	152	5	872e7374dac64be2c8ebe71e88a2ec6814168d89
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB4 PDE3B MYO6 MYO1B ADAM22 ACSL4 TRPM5	1.17e-06	157	152	7	2c5295043611bac7dfa4aef2146681bce4a33a8f
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	PDE3B RAPGEF6 ACVR2A NT5C1B ANKRD44 TC2N ANKRD12	1.44e-06	162	152	7	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HAUS6 PRRX1 IKBIP FREM1 SGO2 RAB4A KNL1	2.14e-06	172	152	7	29c8510f26527d487d0fc3543102d067cdb281a6
ToppCell	3'-Adult-Appendix-Epithelial-mature_enterocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRRX1 KIF27 CPT1B FSIP2 HIBCH LRRC3B SGO2	2.50e-06	176	152	7	30adf8f1638c6244586f8101c2590bb964dfae00
ToppCell	3'-Adult-Appendix-Epithelial-mature_enterocytic-Colonocyte\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRRX1 KIF27 CPT1B FSIP2 HIBCH LRRC3B SGO2	2.50e-06	176	152	7	23fa02d4c39e0b8faa1658116d50b6233a952ccc
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAPGEF5 SYNE1 SAMD9L AKAP9 ARHGAP29 PCM1 HSP90AB1	2.69e-06	178	152	7	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB4 ABCA3 CAMSAP3 SLC34A2 ACSL4 TC2N PATJ	2.90e-06	180	152	7	b798a3fa2dd15b68aa4267f665559527043dcc07
ToppCell	Control-Epithelial_cells-AT2\|Control / group, cell type (main and fine annotations)	CACNB4 ABCA3 RAPGEF5 SYNE1 SLC34A2 ADGRV1 ACSL4	2.90e-06	180	152	7	198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	PDE3B RAPGEF6 SPTAN1 TFRC ANKRD44 TC2N ANKRD12	3.00e-06	181	152	7	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB4 ABCA3 CAMSAP3 SLC34A2 TF TC2N PATJ	3.12e-06	182	152	7	1e2149b222a3e9f64841aed45288a6f29394e7b0
ToppCell	COVID-19-lung-AT1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ABCA3 SH3GL3 TBC1D2 SLC34A2 MYO1B ADGRV1 PATJ	3.23e-06	183	152	7	7b1a385ed54f93bfe85bf0c162e42d05d516b45c
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNB4 ABCA3 RAPGEF5 SLC34A2 ADGRV1 SLC9C1 PATJ	3.23e-06	183	152	7	6847c1252d6bb105524f812658112517fd351eab
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3B KSR2 MYO1B ADAM22 FREM1 FRY THRB	3.23e-06	183	152	7	b5ede5a0048c585b73c00e88aeddbcaf669347b1
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 FREM1 DNAH1 LOXHD1 MYH15 PCDH10 DNAH9	3.35e-06	184	152	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 FREM1 DNAH1 LOXHD1 MYH15 PCDH10 DNAH9	3.35e-06	184	152	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	Control-Neu_4\|World / 5 Neutrophil clusters in COVID-19 patients	PDE3B FANCD2 DDX50 SGO2 KCNMB3 AQR KNL1	3.35e-06	184	152	7	ce7f044956613118ee2e9fb6af2455c3166cb414
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 FREM1 DNAH1 LOXHD1 MYH15 PCDH10 DNAH9	3.35e-06	184	152	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NPC1 ABCA3 NUCB2 SLC34A2 TFRC ACSL4 TC2N	3.47e-06	185	152	7	fd51fef8c69e34c72017d8371ab0a0d7be5701f2
ToppCell	PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NPC1 ABCA3 NUCB2 SLC34A2 TFRC ACSL4 TC2N	3.47e-06	185	152	7	bea26e369ae91006052b973cd89b4c49afa9e553
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB4 ABCA3 SLC34A2 ADGRV1 ACSL4 TC2N PATJ	3.60e-06	186	152	7	e83718fabb057100835d3357df407f283d23fe16
ToppCell	PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NPC1 ABCA3 NUCB2 SLC34A2 TFRC ACSL4 TC2N	3.73e-06	187	152	7	6ab51e17a7782c2ae6394cad813dc3a2cde70c89
ToppCell	PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NPC1 ABCA3 NUCB2 SLC34A2 TFRC ACSL4 TC2N	3.73e-06	187	152	7	e176b5b051690f840f3b12c8f7c4cc10cbe2bbae
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB4 ABCA3 SLC34A2 ADGRV1 ACSL4 TC2N PATJ	3.86e-06	188	152	7	4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NPC1 MYO6 TBC1D2 ADGRG6 SLC9C1 ARHGAP29 PATJ	3.86e-06	188	152	7	43a3a59f92ad93509d4166bd025aed0b1b39a008
ToppCell	COPD-Epithelial-ATII\|COPD / Disease state, Lineage and Cell class	ABCA3 RAPGEF5 SLC34A2 MYO1B ADGRV1 SLC9C1 IGSF3	3.86e-06	188	152	7	eb6d79d733b53f64ca615bb777c64ed456866549
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	ABCA3 MYO6 SLC34A2 MYO1B ADGRV1 SLC9C1 PATJ	3.86e-06	188	152	7	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NPC1 ABCA3 NUCB2 SLC34A2 TFRC ACSL4 TC2N	3.86e-06	188	152	7	562f5984efdbbcb8f53ddcee033ccbf9eb678425
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	RAPGEF5 KSR2 ADGRV1 FRY THRB TC2N PATJ	4.00e-06	189	152	7	7659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NPC1 ABCA3 NUCB2 SLC34A2 TFRC ACSL4 TC2N	4.14e-06	190	152	7	8ff8c586237cf15f930416710bcff45205fe6f70
ToppCell	E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NPC1 ABCA3 NUCB2 SLC34A2 TFRC ACSL4 TC2N	4.28e-06	191	152	7	08b1d3b3be78bf7fd9e9039027e35275f2be88d0
ToppCell	E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NPC1 ABCA3 NUCB2 SLC34A2 TFRC ACSL4 TC2N	4.28e-06	191	152	7	f896fb490c4a17adac5e00ed9b6e6145eab1e564
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NPC1 CACNB4 ABCA3 RAPGEF5 SLC34A2 ADGRV1 PATJ	4.28e-06	191	152	7	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	PND14-Epithelial-Epithelial_Alveolar\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NPC1 ABCA3 NUCB2 SLC34A2 TFRC ACSL4 TC2N	4.28e-06	191	152	7	5f8b3b2d38b37027901db9a1cccdbd1ff70f29de
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NPC1 ABCA3 NUCB2 SLC34A2 TFRC ACSL4 TC2N	4.28e-06	191	152	7	2f71f1fb6b5872d84860840b22e789a87ab14eec
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NPC1 ABCA3 NUCB2 SLC34A2 TFRC ACSL4 TC2N	4.28e-06	191	152	7	4ab3056f9af2a6caed39f32288562f480811cd7b
ToppCell	Control-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	ABCA3 RAPGEF5 SYNE1 SLC34A2 MYO1B ARHGAP29 PATJ	4.43e-06	192	152	7	1bfd022d5b87cf8a5d5069f559339a553a52a0a2
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	RAPGEF5 KSR2 ADGRV1 FRY THRB TC2N PATJ	4.43e-06	192	152	7	b99f8236ef4ccdc75c02abea381cae6453205f6f
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	PDE3B USP9X ADGRV1 MED1 DENND1B AKAP9 AQR	4.59e-06	193	152	7	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PDE3B TBX4 PSD3 ADAM22 FREM1 ADGRG6 THRB	4.74e-06	194	152	7	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ABCA3 MYO6 SYNE1 SLC34A2 MYO1B ADGRV1 PATJ	4.74e-06	194	152	7	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	Control-Multiplet\|Control / Disease state, Lineage and Cell class	ABCA3 RAPGEF5 SYNE1 SLC34A2 MYO1B ARHGAP29 PATJ	4.91e-06	195	152	7	618900c80bea09d46dad3f741bd1bff8bf0a64ee
ToppCell	RA-02._Fibroblast_II\|RA / Chamber and Cluster_Paper	PDE3B CHD9 ANKRD44 PPP3CA TC2N UGGT2 FYN	4.91e-06	195	152	7	6a02ebbeb3199447ddce64d92d8809436e040eba
ToppCell	Control-Multiplet-Multiplet\|Control / Disease state, Lineage and Cell class	ABCA3 RAPGEF5 SYNE1 SLC34A2 MYO1B ARHGAP29 PATJ	4.91e-06	195	152	7	06ac685855e14e4dd2cbe6d0e73f894f2eeff91f
ToppCell	Control-Epithelial\|Control / Disease state, Lineage and Cell class	ABCA3 SYNE1 SLC34A2 MYO1B ADGRV1 SLC9C1 PATJ	4.91e-06	195	152	7	1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa
ToppCell	Control-Neu_4\|Control / 5 Neutrophil clusters in COVID-19 patients	FANCD2 CSE1L DDX50 UGGT2 KCNMB3 AQR KNL1	5.07e-06	196	152	7	b8b7b54ca17a08fa775507bb22b1c7248ada8f40
ToppCell	RA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	PDE3B ANKRD44 PPP3CA TC2N UGGT2 FLRT2 FYN	5.07e-06	196	152	7	e8cbda03837f1f26470a9d93aa7fdaa04e08e38a
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PDE3B SYNE1 ANKRD44 TC2N AKAP9 ANKRD12 PCM1	5.25e-06	197	152	7	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ABCA3 SLC34A2 TF TFRC ACSL4 AKAP9 PATJ	5.25e-06	197	152	7	1485933986921ff45669d9b7501c8d17050b3e97
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ABCA3 NUCB2 SLC34A2 TF TFRC ACSL4 P4HB	5.25e-06	197	152	7	1638959d7aecb9fc5285eb7e4a3103ca437989e2
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNB4 SYNE1 KSR2 ADCY2 ADAM22 FRY THRB	5.42e-06	198	152	7	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ABCA3 SLC34A2 ADGRV1 TF ACSL4 AKAP9 PATJ	5.42e-06	198	152	7	285f729140b1df029c24f6ca1d2438470ac51794
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNB4 SYNE1 SPTAN1 KSR2 ADAM22 FRY PPP3CA	5.42e-06	198	152	7	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	CUL1 VPS13D PPP3CA AKAP9 ZNF644 ANKRD12 FYN	5.42e-06	198	152	7	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA3 MYO6 SLC34A2 MYO1B ADGRV1 CDKL5 SLC9C1	5.61e-06	199	152	7	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNB4 ABCA3 MYO6 SLC34A2 MYO1B ADGRV1 CDKL5	5.61e-06	199	152	7	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6\|World / Primary Cells by Cluster	RAPGEF5 SPTAN1 PSD3 AKAP9 ANKRD12 FLRT2 HSP90AB1	5.61e-06	199	152	7	1b1bccf4293f11048709d15a3c892c0edf3da3d2
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NPC1 CACNB4 ABCA3 SYNE1 SLC34A2 ADGRV1 ACSL4	5.61e-06	199	152	7	2dc33804f6691d7c9682e6c9b885e945fb97fc36
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal\|World / Primary Cells by Cluster	RAPGEF5 SPTAN1 PSD3 AKAP9 ANKRD12 FLRT2 HSP90AB1	5.61e-06	199	152	7	4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB4 PDE3B MYO6 MYO1B ADAM22 FREM1 ARHGAP29	5.61e-06	199	152	7	3cd6383c50ce342fe5c175e2e50784d634a90e80
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ABCA3 CAMSAP3 SLC34A2 ADGRV1 ACSL4 AKAP9 PATJ	5.79e-06	200	152	7	e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PDE3B MYO6 RAPGEF5 SPTAN1 FRY SAMD9L ARHGAP29	5.79e-06	200	152	7	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PDE3B MYO6 RAPGEF5 SPTAN1 FRY PPP3CA ARHGAP29	5.79e-06	200	152	7	89a6da2bdedc6b1ad0675c8753bf2b763a99af6a
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PDE3B MYO6 RAPGEF5 SPTAN1 FRY PPP3CA ARHGAP29	5.79e-06	200	152	7	b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c
ToppCell	Sigmoid-Dendritic_cell-cDC1\|Dendritic_cell / Region, Cell class and subclass	ENOX1 MYO6 FZD3 ACVR2A RUFY3 CDKL5 THRB	5.79e-06	200	152	7	09deb831fc2c8a8867cc850f3aa094a5e48489ff
ToppCell	mild-CD8+_T_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PDE3B CPA5 NUCB2 SAMD9L PCDH10 PCM1 HSP90AB1	5.79e-06	200	152	7	c825320599a61a4c629d736f5c0fd6f1f405540a
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A5 ADGRV1 ADCY2 FREM1 MYH15 DNAH9	1.86e-05	160	152	6	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A5 ADGRV1 ADCY2 FREM1 MYH15 DNAH9	1.86e-05	160	152	6	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HAUS6 PDE3B NUCB2 ACVR2A PATJ FYN	1.93e-05	161	152	6	5fba13f0aa5002f7eefe219e2c6a07e163f1a50d
ToppCell	T_cells-Tph_and_Tfh\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	SEMA4D PDE3B CPA5 FZD3 KSR2 FYN	2.00e-05	162	152	6	146058f2d60846376078916055d08f68562e3a7c
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CPA5 FZD3 ALG2 TFR2 THRB SPEN	2.29e-05	166	152	6	bcdaab49bde5beba750b76fdcc3781a3c12c4fff
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CPA5 FZD3 ALG2 TFR2 THRB SPEN	2.29e-05	166	152	6	5e3b998d740b24f790fad37350d704ca0ea10b77
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1B ADCY2 PCDH20 ADGRG6 TRPM5 PCDH10	2.62e-05	170	152	6	17bd7fd25a2657cb536ad47e294332920f759e95
ToppCell	PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABCA3 NUCB2 CAMSAP3 SLC34A2 TFRC ACSL4	2.62e-05	170	152	6	4ce81608111b9ee7cb974dad2c182f38db3dcd79
ToppCell	367C-Myeloid-Dendritic-cDC_proliferating_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ADAM22 ADGRG6 TFR2 SUGP2 SGO2 KNL1	2.71e-05	171	152	6	0eea035fde32cc2a75a0d4227911edb5d54ed47e
ToppCell	E18.5-samps-Epithelial-Alveolar_epithelial-AT2\|E18.5-samps / Age Group, Lineage, Cell class and subclass	NPC1 ABCA3 NUCB2 SLC34A2 ACSL4 TC2N	2.89e-05	173	152	6	f6e36ea98a9c669ff393d141455aaecef083f738
ToppCell	Epithelial-Epithelial-C_(AT2)\|Epithelial / shred on cell class and cell subclass (v4)	NPC1 ABCA3 NUCB2 SLC34A2 ACSL4 TC2N	2.89e-05	173	152	6	f57cbf5bd2a9e5db47b4919e9cd5e50781c1a990
ToppCell	5'-Adult-Appendix-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SEMA4D PDE3B SYNE1 LCP1 ANKRD44 FYN	3.18e-05	176	152	6	6b06da40eb97ea2db09f3a769494738b3e5fe3fa
Drug	Clorgyline	CYP2B6 MYO6 FZD3 CHD9 MANEA AKAP9 ZNF644 ANKRD12 NUDCD1 PCM1	1.87e-07	168	151	10	ctd:D003010
Drug	Polylysine	TF TFR2 TFRC	2.86e-07	3	151	3	CID000162282
Drug	bmep	TF TFR2 TFRC	2.86e-07	3	151	3	CID003081158
Drug	C6-NBD-SM	TF TFR2 TFRC	2.83e-06	5	151	3	CID006439924
Drug	Myosmine [532-12-7]; Down 200; 27.4uM; PC3; HT_HG-U133A	PDE3B SYNE1 SPTAN1 TBC1D2 EML2 CPT1B MED25 PCM1 WDTC1	6.39e-06	195	151	9	3737_DN
Drug	Guaifenesin [93-14-1]; Up 200; 20.2uM; MCF7; HT_HG-U133A	IFT140 PDE3B ABCA2 FOXN3 GRAMD4 RXRA TDRD3 MED25 PATJ	6.93e-06	197	151	9	3431_UP
Drug	alpha-estradiol; Down 200; 0.01uM; HL60; HT_HG-U133A	SEMA4D ABCA2 PSD3 TFR2 VPS13D MAGED2 UGGT2 FLRT2 WDTC1	6.93e-06	197	151	9	6169_DN
Drug	Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; MCF7; HT_HG-U133A	IFT140 ABCA2 NAA60 SPTAN1 CENPO CHD9 FOXN3 AKAP9 WDTC1	7.22e-06	198	151	9	5304_UP
Drug	Ferrosanol	TF TFR2 TFRC	2.33e-05	9	151	3	CID000028366
Drug	ferric pyrophosphate	TF TFRC	4.37e-05	2	151	2	ctd:C049051
Drug	AC1NSWD2	SYNE1 TOP2B	4.37e-05	2	151	2	CID005318091
Drug	tyrphostin 8	TF TFRC	4.37e-05	2	151	2	CID000092970
Drug	elinafide	CPA1 TOP2B	4.37e-05	2	151	2	CID000444911
Drug	titanium(IV) transferrin	TF TFRC	4.37e-05	2	151	2	ctd:C117091
Drug	Suramin sodium salt; Down 200; 10uM; PC3; HT_HG-U133A	SPTAN1 EML2 NCBP1 ZZEF1 GRAMD4 CSE1L MYH15 WDTC1	4.72e-05	194	151	8	7529_DN
Drug	ST021200; Up 200; 10uM; PC3; HT_HG-U133A	SEMA4D RAPGEF5 CNTNAP1 CENPO EML2 FOXN3 CPT1B WDTC1	4.72e-05	194	151	8	7493_UP
Drug	Hesperidin [520-26-3]; Up 200; 6.6uM; MCF7; HT_HG-U133A	IFT140 ABCA2 NCBP1 LCP1 TDRD3 CSE1L AKAP9 PCM1	4.90e-05	195	151	8	5313_UP
Drug	Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A	SEMA4D PDE3B PSD3 RUFY3 TDRD3 CSE1L PATJ WDTC1	4.90e-05	195	151	8	7225_DN
Drug	Erythromycin [114-07-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A	SEMA4D TDRD3 SUGP2 PATJ FYN PCM1 AQR WDTC1	4.90e-05	195	151	8	5329_DN
Drug	Tadjakonine [11087-94-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A	SEMA4D IFT140 SYNE1 CPT1B RUFY3 THRB PCM1 AQR	4.90e-05	195	151	8	2820_DN
Drug	Amoxapine [14028-44-5]; Down 200; 12.8uM; PC3; HT_HG-U133A	SPTAN1 APAF1 PSD3 FOXN3 CPT1B PATJ FYN AP3D1	4.90e-05	195	151	8	6650_DN
Drug	PF-00539758-00 [351321-34-1]; Up 200; 10uM; MCF7; HT_HG-U133A	ABCA2 SPTAN1 CENPO ZZEF1 ADAM22 TFR2 SERPINA10 FYN	5.08e-05	196	151	8	6416_UP
Drug	felodipine; Down 200; 10uM; MCF7; HT_HG-U133A_EA	SEMA4D ERO1A MANEA MED1 TDRD3 CSE1L HIBCH SUGP2	5.08e-05	196	151	8	848_DN
Drug	Cyclosporin A [59865-13-3]; Down 200; 3.4uM; PC3; HT_HG-U133A	RAPGEF5 SYNE1 SPTAN1 CENPO FOXN3 CSE1L MED25 MYH15	5.08e-05	196	151	8	4586_DN
Drug	Ioversol [87771-40-2]; Down 200; 5uM; MCF7; HT_HG-U133A	TBC1D2 PSD3 CENPO MED1 RUFY3 VPS13D SUGP2 ANKRD12	5.26e-05	197	151	8	3365_DN
Drug	Fenspiride hydrochloride [5053-08-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A	TBC1D2 EML2 TWF2 FOXN3 ADAM22 VPS13D AKAP9 WDTC1	5.26e-05	197	151	8	2269_DN
Drug	Propidium iodide [25535-16-4]; Up 200; 6uM; PC3; HT_HG-U133A	PDE3B ENOX1 GATM CPT1B ZZEF1 FRY MED25 PATJ	5.26e-05	197	151	8	5803_UP
Drug	Moxonidine [75438-57-2]; Down 200; 16.6uM; PC3; HT_HG-U133A	SEMA4D IFT140 ABCA3 SLC34A2 CPT1B THRB MED25 WDTC1	5.26e-05	197	151	8	4084_DN
Drug	Mafenide hydrochloride [138-37-4]; Up 200; 18uM; HL60; HG-U133A	PDE3B APAF1 MANEA UFL1 ACSL4 SUGP2 FLRT2 LRIF1	5.26e-05	197	151	8	1441_UP
Drug	Alprostadil [745-65-3]; Down 200; 11.2uM; PC3; HT_HG-U133A	SEMA4D IFT140 ABCA3 SLC34A2 CPT1B ADAM22 MED25 PCM1	5.46e-05	198	151	8	4099_DN
Drug	Bacitracin [1405-87-4]; Down 200; 2.8uM; HL60; HT_HG-U133A	SYNE1 CENPO RUFY3 CSE1L MAGED2 AP3D1 PCM1 WDTC1	5.46e-05	198	151	8	3109_DN
Drug	Nicardipine hydrochloride [54527-84-3]; Down 200; 7.8uM; PC3; HT_HG-U133A	PSD3 MANEA VPS13D SUGP2 PCM1 AQR IGSF3 WDTC1	5.46e-05	198	151	8	6297_DN
Drug	Zidovudine, AZT [30516-87-1]; Up 200; 15uM; MCF7; HT_HG-U133A	PDE3B RAPGEF5 APAF1 ADAM22 FRY VPS13D THRB FLRT2	5.46e-05	198	151	8	3211_UP
Drug	Protoveratrine A [143-57-7]; Up 200; 5uM; HL60; HT_HG-U133A	SPTAN1 APAF1 MYO1B ADCY2 TFR2 THRB MCM3AP SERPINA10	5.65e-05	199	151	8	2144_UP
Drug	Thiorphan [76721-89-6]; Down 200; 15.8uM; MCF7; HT_HG-U133A	SPTAN1 FOXN3 MED1 GRAMD4 TDRD3 SUGP2 FYN RBM41	5.65e-05	199	151	8	6249_DN
Drug	Flucytosine [2022-85-7]; Down 200; 31uM; HL60; HT_HG-U133A	SPTAN1 APAF1 EML2 MYO1B RXRA TDRD3 FLRT2 WDTC1	5.65e-05	199	151	8	3073_DN
Drug	Naproxen [22204-53-1]; Up 200; 17.4uM; HL60; HT_HG-U133A	SYNE1 TBC1D2 PSD3 FOXN3 TDRD3 MED25 PCM1 WDTC1	5.86e-05	200	151	8	1869_UP
Drug	Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A	ERO1A SYNE1 NCBP1 ADAM22 TDRD3 MCM3AP PATJ PCM1	5.86e-05	200	151	8	3425_UP
Drug	maltolate	APAF1 TF TFR2 TFRC	8.29e-05	35	151	4	CID000092427
Disease	iron biomarker measurement, transferrin saturation measurement	TF TFR2 TFRC	4.15e-05	14	146	3	EFO_0004461, EFO_0006333
Disease	transferrin saturation measurement	TF TFR2 TFRC	6.34e-05	16	146	3	EFO_0006333
Disease	mean corpuscular hemoglobin concentration	CUL1 NUP50 IFT140 PSD3 ENTHD1 MYO1B LCP1 TF TFR2 TFRC THRB ANKRD12 FYN LRIF1 TXNDC8 HSP90AB1	1.22e-04	1105	146	16	EFO_0004528
Disease	iron biomarker measurement, transferrin measurement	PSD3 TF TFRC	1.27e-04	20	146	3	EFO_0004461, EFO_0006341
Disease	Weissenbacher-Zweymuller syndrome (implicated_via_orthology)	ACVR2A TFRC	1.45e-04	4	146	2	DOID:4258 (implicated_via_orthology)
Disease	body fat percentage	NPC1 SEMA4D KIF27 APAF1 ZZEF1 TFRC ANKRD44 CSE1L TET1 PATJ	1.67e-04	488	146	10	EFO_0007800
Disease	urate measurement, bone density	PDE3B SYNE1 TBC1D2 PSD3 COL6A5 LCP1 FREM1 DNAH1 FSIP2 UGGT2 DNAH9	2.70e-04	619	146	11	EFO_0003923, EFO_0004531
Disease	BMI-adjusted waist circumference, physical activity measurement	TBX4 CPA5 NUCB2 CPA1 ADGRG6	3.74e-04	123	146	5	EFO_0007789, EFO_0008002
Disease	muscular atrophy (biomarker_via_orthology)	APAF1 TFRC HSP90AB1	3.95e-04	29	146	3	DOID:767 (biomarker_via_orthology)
Disease	lethal congenital contracture syndrome (is_implicated_in)	CNTNAP1 ADGRG6	5.02e-04	7	146	2	DOID:0060558 (is_implicated_in)
Disease	Colorectal Carcinoma	ABCA3 SYNE1 EML2 MYO1B TFRC ACSL4 CDKL5 CSE1L AKAP9 LRRC3B MCM3AP	7.69e-04	702	146	11	C0009402
Disease	Cataract microcornea syndrome	ABCA3 CRYBB1	8.56e-04	9	146	2	C1861829
Disease	Prostatic Neoplasms	PRRX1 TBC1D2 NUCB2 RXRA ACSL4 PPP3CA P4HB PATJ SPEN HSP90AB1	1.02e-03	616	146	10	C0033578
Disease	Malignant neoplasm of prostate	PRRX1 TBC1D2 NUCB2 RXRA ACSL4 PPP3CA P4HB PATJ SPEN HSP90AB1	1.02e-03	616	146	10	C0376358
Disease	immature reticulocyte measurement	TFR2 TFRC THRB	1.03e-03	40	146	3	EFO_0803545
Disease	unipolar depression, bipolar disorder	ENOX1 SYNE1 ADCY2 DENND1B MYH15	1.10e-03	156	146	5	EFO_0003761, MONDO_0004985
Disease	complement C1q tumor necrosis factor-related protein 5 measurement	APAF1 IKBIP	1.30e-03	11	146	2	EFO_0801494
Disease	creatinine measurement	TBX4 GATM CHD9 ADGRV1 ACVR2A MED1 LCP1 ADCY2 CDKL5 FRY PPP3CA PCDHGB4 DUSP11	1.38e-03	995	146	13	EFO_0004518
Disease	ficolin-3 measurement	NUCB2 WDTC1	1.55e-03	12	146	2	EFO_0020392
Disease	Cooley's anemia	TFR2 TFRC	1.55e-03	12	146	2	C0002875
Disease	Thalassemia Intermedia	TFR2 TFRC	1.55e-03	12	146	2	C0271979
Disease	iron biomarker measurement, serum iron measurement	TF TFR2	1.55e-03	12	146	2	EFO_0004461, EFO_0006332
Disease	Thalassemia Minor	TFR2 TFRC	1.55e-03	12	146	2	C0085578
Disease	beta Thalassemia	TFR2 TFRC	1.55e-03	12	146	2	C0005283
Disease	xanthine measurement	KSR2 ADAM22	1.83e-03	13	146	2	EFO_0010548
Disease	receptive language perception, parental genotype effect measurement	ENOX1 MEI4	2.13e-03	14	146	2	EFO_0005686, EFO_0005939
Disease	phoneme awareness	ZNFX1 CSE1L	2.13e-03	14	146	2	EFO_0021812
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	NPC1 SEMA4D KIF27 ZZEF1 ANKRD44 TET1 PATJ	2.30e-03	364	146	7	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	Hemoglobin F Disease	TFR2 TFRC	2.45e-03	15	146	2	C0019025
Disease	Premature atrial contractions	KSR2 ANKRD44 PCDHGB4	2.58e-03	55	146	3	HP_0006699
Disease	Malignant neoplasm of breast	ABCA3 SYNE1 SPTAN1 MANEA PCDH20 TFRC AKAP9 MAGED2 LRRC3B ZNF644 ARHGAP29 SPEN DNAH9	2.68e-03	1074	146	13	C0006142
Disease	Tremor, Rubral	NPC1 CACNB4	2.79e-03	16	146	2	C0750940
Disease	Ataxia, Appendicular	NPC1 CACNB4	2.79e-03	16	146	2	C0750937
Disease	Ataxia, Motor	NPC1 CACNB4	2.79e-03	16	146	2	C0278161
Disease	Ataxia, Sensory	NPC1 CACNB4	2.79e-03	16	146	2	C0240991
Disease	Abnormal coordination	NPC1 CACNB4	2.79e-03	16	146	2	C0520966
Disease	Ataxia, Truncal	NPC1 CACNB4	2.79e-03	16	146	2	C0427190
Disease	erythrocyte cadmium measurement	PSD3 THRB	3.15e-03	17	146	2	EFO_0007807
Disease	Eye Abnormalities	APAF1 FREM1	3.15e-03	17	146	2	C0015393
Disease	uterine fibroid	SYNE1 SH3GL3 THRB ANKRD12 FYN	3.18e-03	199	146	5	EFO_0000731
Disease	retinal vasculature measurement	PSD3 RXRA FRY CSE1L PATJ DNAH9 RBM18 KNL1	4.32e-03	517	146	8	EFO_0010554
Disease	fatty acid measurement, linoleic acid measurement	KIF27 LCP1 UVRAG	4.70e-03	68	146	3	EFO_0005110, EFO_0006807
Disease	kidney disease (biomarker_via_orthology)	GATM PPP3CA	4.80e-03	21	146	2	DOID:557 (biomarker_via_orthology)
Disease	congenital heart disease (implicated_via_orthology)	CHD9 ADCY2 RXRA	4.90e-03	69	146	3	DOID:1682 (implicated_via_orthology)
Disease	susceptibility to mononucleosis measurement	CUL1 MANEA ADCY2	4.90e-03	69	146	3	EFO_0008403

Protein segments in the cluster

Peptide	Gene	Start	Entry
ESEHFTKEHGLDKFF	NT5C1B	476	Q96P26
ADTLDKLFDHAVSKF	ACSL4	76	O60488
AAKNKIFLFDIHTSG	APAF1	816	O14727
ASDIKLEKFSISAHG	ABCF1	301	Q8NE71
LEKFSISAHGKELFV	ABCF1	306	Q8NE71
DLSEQLKQKHGEISF	AKAP9	961	Q99996
FSFKTEEKDGLLLHA	CNTNAP1	201	P78357
DHFLDANGALKKTEA	CYP2B6	411	P20813
SKGFELHFSSFELIK	CSMD2	1196	Q7Z408
VNISFHLSAGEDKIK	ADGRG6	451	Q86SQ4
DFVKDHGNIKAFISI	CPA1	291	P15085
ITAFHEKGSLSDFLK	ACVR2A	266	P27037
STKKGNFHEIFNLTE	GRAMD4	441	Q6IC98
DFKPSHGILEFADKQ	ADGRV1	3966	Q8WXG9
KEKSDAVHLFSGSQF	ADAM22	321	Q9P0K1
AQEHKISLFEGANFK	CRYBB1	146	P53674
ESTHRFEGLFAKLEK	ABCA3	801	Q99758
LKDNFGFIETANHDK	CSDE1	526	O75534
FFFKHILKAALAETD	AQR	121	O60306
DFHLEFGEKSNAKIK	ANKRD12	611	Q6UB98
EKSKANHFLILFRDS	CAMSAP3	1151	Q9P1Y5
TAISFDAKDFLHIKE	CACNB4	116	O00305
IAEGTFSHLTKLKEF	FLRT2	221	O43155
LSFIAKNDEGATHEK	AP3D1	1021	O14617
FLFHGNKTEDTPDKK	NUP50	236	Q9UKX7
VKQFDFLFHKSGALE	RBM18	51	Q96H35
KSLFQGADRHSFLKA	RBM41	156	Q96IZ5
KKFKDDSNHTIGVEF	RAB4A	36	P20338
EFIEFLKTFHKTGQE	RABGEF1	141	Q9UJ41
DLNNHFKSLGSSDLK	HIBCH	371	Q6NVY1
KDHQFLEGKLYSSID	NUDCD1	316	Q96RS6
DHFSLINKEKSDGSK	PCDHGB4	176	Q9UN71
QTLKDFQHIDEAGKD	ENTHD1	101	Q8IYW4
FHLDENTGVIKLFSK	PCDH20	371	Q8N6Y1
EAFSKNLKLGIHEDS	HSP90AB1	431	P08238
HSLFGDVKKLITDEF	MAGED2	406	Q9UNF1
GRSNKALHLKSDAEF	LRIF1	556	Q5T3J3
ALHLKSDAEFKKIFG	LRIF1	561	Q5T3J3
LAKFHEVFKTLAESD	NCBP1	566	Q09161
HKLAAQGKFVTTEFE	GATM	236	P50440
KIHKEDGDILASNFS	NAA60	76	Q9H7X0
EDKLPFSKHSDVFAL	KSR2	846	Q6VAB6
KPSLLKAHQFEGDSF	MCM3AP	561	O60318
KHKDAATDSRAFIFL	LOXHD1	1431	Q8IVV2
FSELKDIKAYLESHG	CPA5	86	Q8WXQ8
EIDHTKSLTDKGFFA	FSIP2	1321	Q5CZC0
KLVATSLEGKFHVFD	DNAAF10	226	Q96MX6
SFGSIDHLQKLDEQK	KIF27	911	Q86VH2
DESKEFVKFFHKQLG	PCM1	1636	Q15154
FDEFIKIFHGLKSTD	LCP1	71	P13796
LATDLKKHFDFLAEF	PDE3B	891	Q13370
ADDFTIQLSDGKHKI	FREM1	1246	Q5H8C1
TGEFIHEKFSQKDLN	FREM1	1686	Q5H8C1
KEDFHLAGASKTILY	KNL1	1131	Q8NG31
EGLSTALQLFDDFKK	MED25	116	Q71SY5
VQFHFTNKDLESLKG	MED25	471	Q71SY5
SKNGIEFIDEHAFKG	LRRC3B	96	Q96PB8
IKLLQSSGADFHKKD	ANKRD44	421	Q8N8A2
SFKGKILFIFIDSDH	P4HB	281	P07237
AERSFSTFGKEKALH	PCDH10	996	Q9P2E7
PKTFFKLHDVNSDGF	NUCB2	246	P80303
LTELKSDFDKHTDRF	IKBIP	246	Q70UQ0
RTIHLGKNFDFQKSD	MANEA	51	Q5SRI9
SHSVLDHKKGDDFFV	NPC1	491	O15118
IHLFGAEFTQVAKKE	ARHGAP29	666	Q52LW3
VNKFLDDLGNAKSHL	BAG2	121	O95816
HFLESLFKFDKDNIG	DNAH1	2991	Q9P2D7
VGKLDAINKHSFNDF	ADCY2	981	Q08462
DFDADKSLLIGVFKH	CHD9	1676	Q3L8U1
DGKLILKTTHNSAFE	IGSF3	726	O75054
KFLHFAKSDSFLDDI	DNASE2B	236	Q8WZ79
DETIFKFKHAVNGFL	DUSP11	171	O75319
FKKHLTNSEPLDLDF	CUL1	521	Q13616
RTEDDLSFHKGEKFQ	FYN	96	P06241
LHESKNLLKSFGESV	FOXN3	66	O00409
FVFSFGPKHNDKELE	COL6A5	2441	A8TX70
AKASSLSEELKHFAD	DSN1	166	Q9H410
EGFNRLSDEFSKSHK	DDX50	76	Q9BQ39
EIFHKGSFFRSDKLV	CC2D1B	781	Q5T0F9
ATFLLQLFEHDKDLK	ABCA2	1921	Q9BZC7
LHFDENSFFAGDKKE	ERO1A	356	Q96HE7
SEAIEKKALLFHASA	FZD3	321	Q9NPG1
KSFKDNDFGILHETL	HAUS6	766	Q7Z4H7
ALDIKEFFDHKNGTP	KCNMB3	171	Q9NPA1
HQVFASFTRKGEKLD	CENPO	281	Q9BU64
HVFGLEKSQLLKEAF	C19orf54	71	Q5BKX5
KLLASADDFGKVHLF	EML2	586	O95834
ALDFHKLGKVEFSGV	DNAH9	456	Q9NYC9
VFKDSKSGFHLEHQL	FRY	1836	Q5TBA9
SHSEQLKEKEKQGFF	CDKL5	766	O76039
FILKEENSNKHLGAD	DENND1B	661	Q6P3S1
GKKFDDENFILKHTG	PPIE	216	Q9UNP9
LFKHFLVEDKSLSGG	SEC24C	1061	P53992
KCLEHLFFFKLIGDT	RXRA	431	P19793
TDKKDSGRLHVDFAQ	ENOX1	206	Q8TC92
ETNKSHLFVDEGLKN	IFT140	631	Q96RY7
SHRLTAKEVFDNDGK	PPP3CA	26	Q08209
EGSHTKADLRDLFQK	CPT1B	621	Q92523
NFDEFSKHLKGLVNL	MED1	146	Q15648
EFTGKEEKTSLLLHN	FANCD2	906	Q9BXW9
SGNLKRDLTHFEKDS	MEI4	166	A8MW99
HELAFKLQSSDLGVK	RUFY3	406	Q7L099
ELLAFQTSEKKFHIG	USP9X	1436	Q93008
ALQDKGSAFSAEHLK	UVRAG	271	Q9P2Y5
RIQSGFSFKEHVDKA	RMDN3	341	Q96TC7
DDLFKLNSKTGNTHL	RAPGEF6	886	Q8TEU7
INNEAFSGIKIEKHF	TDRD3	461	Q9H7E2
HKASQLFSEKISGAE	SH3GL3	11	Q99963
LHDKKSQDFGNLFSF	TOP2B	1436	Q02880
FGSDKEKSQILFHGV	SLC9C1	391	Q4G0N8
DLDNFTSKGKHLLSE	SYNE1	2141	Q8NF91
GETEKHNFSVERDFK	TC2N	16	Q8N9U0
TFFKDKQQALGDHLD	PLEKHG4	841	Q58EX7
GVKITSKAAFIDHFN	SAMD9L	251	Q8IVG5
TDLTFKTKLFDNHFG	MYH15	556	Q9Y2K3
LKDVTFIHEGNKTFL	RAPGEF5	501	Q92565
KFGQAEKTELDAHFE	SH3GLB2	26	Q9NR46
ASFEHGKKQENDLDL	SHOC1	506	Q5VXU9
KGVHDLEKDNFFSLT	SGO2	831	Q562F6
AEEERKLHSFLKSFG	SPATA31D4	86	Q6ZUB0
DHLNLTSFKFLGKNE	SEMA4D	136	Q92854
KLVHANFGTKKDFED	TFRC	231	P02786
HTAFQSLDKDKSGFI	PVALEF	61	A0A1B0GWK0
FHLKTESNGKAFTDK	TET1	1266	Q8NFU7
AAVFKETFKSLSHID	ALG2	181	Q9H553
SFHFKNGEDAPDLLK	SLC34A2	251	O95436
AEEERKLHSFLKSFG	SPATA31D3	86	P0C874
LDDFKGKFPEQAHSS	WDTC1	456	Q8N5D0
KFEEHGKAFNLFSNI	ZNF107	581	Q9UII5
TAFSQLAFAGKKEHD	CSE1L	901	P55060
EHFGKDKSKEFQLFS	TF	291	P02787
DKSKEFQLFSSPHGK	TF	296	P02787
GFFTDEDTHLVKKFT	TRPM5	786	Q9NZQ8
STDTSLKDGLFHEFK	SPEN	346	Q96T58
ALFNHIDKSGLKDSS	RPAP3	641	Q9H6T3
LDLGKSFHSQQKEIE	PATJ	831	Q8NI35
QGLLKKHEAFETDFT	SPTAN1	1906	Q13813
ITDAFHDKGFQKIKE	SYCP2L	31	Q5T4T6
GGKVDLEAFSHFTKI	THRB	261	P10828
AGFHTIKDDIKFSQL	SUGP2	336	Q8IX01
FDFKKVSLLHSLLQD	nan	211	Q6ZUG5
KDTNEFKTFLTAAGH	TXNDC8	6	Q6A555
EKIKGVSSNLFFVEH	ZNFX1	1101	Q9P2E3
TQGSFAFIHKDFDVK	SERPINA10	161	Q9UK55
TDLAPLSQKFHKFDS	ZNF630	166	Q2M218
FKKEEASSLNSLHLF	ZNF644	761	Q9H582
KTLKAHGFEEIRATF	ZZEF1	2361	O43149
LHIVKADENNAFGSK	TBX4	196	P57082
KEKDVLNIFSVASGH	UGGT2	1226	Q9NYU1
KKNFSVSHLLDLEEA	PRRX1	31	P54821
HLGKNNEFSKLVAEE	PSD3	606	Q9NYI0
SLDNAVLGDDKFHAK	TFR2	506	Q9UP52
GIHATEELKEFFAKA	TWF2	6	Q6IBS0
FADDTQAALTKHLLK	UFL1	561	O94874
DFLSQQGKIEHLKDD	TBC1D2	446	Q9BYX2
GKSKFDDSLVHINIF	VPS13D	1776	Q5THJ4
KYDDKVFSHLSLELA	DYNLT2	116	Q8IZS6
FFAVHLKEGSEAASK	MYO1B	1046	O43795
FGKFVEIHFNEKSSV	MYO6	206	Q9UM54